THYMATRON
ECT
In 1938 the first patient ever to receive ECT made a full recovery. Now, nearly 90 years later, ECT remains an established treatment for severe depression. The Thymatron device is an FDA-cleared medical device intended to treat catatonia or a severe major depressive episode associated with major depressive or bipolar disorder in patients age 13 years and older who are treatment-resistant or who require a rapid treatment response (Device class II).
SAFETY AND EFFICACY
The Thymatron's positive safety profile derives from its multiple redundant levels of error protection and operating efficiency.
Several proprietary algorithmic methods in the Thymatron instrument automatically provide optimal stimulus delivery, seizure quality analysis, and seizure endpoint determination.
FULL INSTALLATION AND SERVICE OPTIONS
Somatics has a team to provide delivery, set-up, and on-site preventive maintenance and device services. We also offer service contracts to ensure predictable costs and availability throughout the device lifespan. Please contact us to discuss your particular needs, and we'll put together a package that suits you.
Contact Somatics
Phone
847-234-6761
800-642-6761 (USA)
Fax
847-234-6763
Email
[email protected]
Please review indications, warnings, cautions, and adverse effects described fully in Thymatron® System IV - Instruction Manual on the Downloads page of this website. This manual download supersedes and replaces all previous versions, which should be discarded.
This website does not gather or retain any user information.